Stockreport

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

Equillium, Inc.  (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
PDF 20% of all subjects that completed the 24-week treatment period achieved SALT = 2029% of completed subjects with moderate to severe disease (baseline SALT 35 to EQ101 wa [Read more]